A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the effect of LEO 130852A gel 1% in maintaining skin thickness in healthy skin treated with steroid.

Phase 1

LEO Pharma

Clobetasol